RAFAEL ALBERTO
LÓPEZ ZORZANO
Profesor contratado doctor
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von David Geffen School of Medicine at UCLA (1)
2018
-
Paclitaxel with inhibitor of apoptosis antagonist, LCL161, for localized triple-negative breast cancer, prospectively stratified by gene signature in a biomarker-driven neoadjuvant trial
Journal of Clinical Oncology, Vol. 36, Núm. 31, pp. 3126-3133